What You Should Know:
- QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory serving medical professionals and facilities throughout the United States, is working with Proscia®, a leading provider of digital and computational pathology solutions, to innovate its practice.
- The laboratory has deployed Proscia’s software to enable its pathologists to work faster and more confidently.
Revolutionizing Pathology: Proscia’s Digital Solutions Leading the Way
Digital pathology is revolutionizing traditional microscopy practices, ushering in a new era of high-resolution imaging with over 1 billion pixels per image, narrating the narrative of a patient’s illness. Empowered by mounting evidence, laboratories are embracing digital pathology to optimize everyday processes, enhance decision-making, and pave the way for groundbreaking AI-driven insights.
Proscia’s software, characterized by its user-friendly interface, extensive capabilities, and adaptability, is empowering pathologists to elevate efficiency and confidence in their regular tasks. This encompasses facilitating seamless collaboration, enabling access to a wider pool of expertise. QDx Pathology Services aims to uphold its innovative stance by leveraging the software’s seamless integration with AI solutions developed by Proscia, its clientele, and its partner ecosystem.
Today’s announcement adds to a string of recent updates from Proscia. Last month, the company attained FDA 510(k) clearance for its Concentriq® AP-Dx solution and initiated the Proscia Ready partner coalition, designed to facilitate the widespread adoption of digital pathology in life sciences and diagnostic laboratories with assurance and efficiency.
“At QDx Pathology Services, we are committed to advancing the standard of excellence in pathology,” said Pierre Mouawad, VP of Laboratory Operations. “Proscia’s software makes it easier for our pathologists to do their best work, empowering them to optimize for speed and precision. We have already seen an impact from our decision to adopt this state-of-the-art solution.”
